期刊文献+

错配修复基因和骨保护素在胃癌中的表达及意义 被引量:2

Expression and significance of mismatch repair gene and osteoprotegerin in human gastric carcinoma
原文传递
导出
摘要 目的研究胃癌组织中错配修复基因MSH2和骨保护素(OPG)的表达、两者间的相关性及与胃癌生物学行为的关系。方法制备组织芯片,应用原位杂交和免疫组化技术检测220例胃癌组织中MSH2和OPG的表达情况。结果MSH2mRNA、OPGmRNA、MSH2蛋白和OPG蛋白在胃癌组织中的阳性表达率分别为57.3%、56.4%、59.6%和55.9%。MSH2和OPG表达均与胃癌的TNM分期、浸润深度、脉管侵犯、淋巴结转移和远处转移呈正相关,与分化程度呈负相关。胃癌中MSH2和OPG的表达呈正相关。MSH2和OPG阳性表达病例的平均生存时间和5年生存率明显低于阴性者。结论胃癌中MSH2和OPG的表达上凋,且两者呈正相关。MSH2和OPG的表达与胃癌的临床病理特征相关,两者的联合测定有利于胃癌诊断和判断预后。 Objective To investigate the relationship between expressions of mismatch repair gene (MSH2) and osteoprotegerin (OPG) as well as their biologic behaviors in gastric carcinoma. Methods The samples obtained from 220 patients with gastric cancer were prepared for tissue chip. Then, the expression of MSH2 and OPG in gastric cancer tissues were detected by in situ hybridization and immunohistochemistry. Results The positive rate was 57.3% in MSH2 mRNA, 56.4% in OPG mRNA, 59.6% in MSH2 protein and 55. 9% in OPG protein. The expressions of MSH2 and OPG were positively associated with TNM stage, invasive deptb, vessel invasion, lymph node and distant metastasis, however, they were negatively associated with degree of differentiation. The positive relationship between MSH2 and OPG expressions was found in gastric cancer. The average survival time and 5 year survival time in patients with positive expression of MSH2 or OPG were shorter than those in patients with negative expressions. Conclusions In gastric carcinoma, the expressions of MSH2 and OPG are up-regulated and there is a positive correlation between two genes. Furthermore, the expressions of MSH2 and OPG are related with clinicopathologic fetures. The combination of MSH2 and OPG is useful for examining and predicting outcome of gastric cancer.
出处 《中华消化杂志》 CAS CSCD 北大核心 2009年第9期540-544,共5页 Chinese Journal of Digestion
基金 浙江省科技厅计划基金资助项目(2006C33060) 杭州市科技发展计划项目(20061133B14)
关键词 胃肿瘤 DNA错配修复 骨保护素 原位杂交 Stomach neoplasms DNA mismatch repair Osteoprotegerin In situ hybridization
  • 相关文献

二级参考文献100

  • 1[1]Tamura G,Kihana T,Nomura K,Terada M,Sugimura T,Hirohashi S.Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.Cancer Res 1991; 51:3056-3058
  • 2[2]Becker KF,Atkinson MJ,Reich U,Becker I,Nekarda H,Siewert JR,Hofler H.E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.Cancer Res 1994; 54:3845-3852
  • 3[3]Tamura G,Sakata K,Nishizuka S,Maesawa C,Suzuki Y,Iwaya T,Terashima M,Saito K,Satodate R.Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.Jpn J Cancer Res 1996; 87:1153-1159
  • 4[4]Kim IJ,Kang HC,Shin Y,Park HW,Jang SG,Han SY,Lim SK,Lee MR,Chang HJ,Ku JL,Yang HK,Park JG.A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and LiFraumeni syndrome.J Hum Genet 2004; 49:591-595
  • 5[5]Guilford P,Hopkins J,Harraway J,McLeod M,McLeod N,Harawira P,Taite H,Scoular R,Miller A,Reeve AE.E-cadherin germline mutations in familial gastric cancer.Nature 1998; 392:402-405
  • 6[6]Tamura G,Yin J,Wang S,Fleisher AS,Zou T,Abraham JM,Kong D,Smolinski KN,Wilson KT,James SP,Silverberg SG,Nishizuka S,Terashima M,Motoyama T,Meltzer SJ.E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.JNatl Cancer Inst 2000; 92:569-573
  • 7[7]Nishizuka S,Tamura G,Terashima M,Satodate R.Loss of heterozygosity during development and progression of differentiated adenocarcinoma of the stomach.J Pathol 1998;185:3843
  • 8[8]Akiyama Y,Nakasaki H,Nihei Z,Iwama T,Nomizu T,Utsunomiya J,Yuasa Y.Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers.Jpn J Cancer Res 1996; 87:595-601
  • 9[9]Semba S,Yokozaki H,Yasui W,Tahara E.Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer.Int J Oncol 1998; 12:1245-1251
  • 10[10]Tamura G,Sakata K,Maesawa C,Suzuki Y,Terashima M,Satoh K,Sekiyama S,Suzuki A,Eda Y,Satodate R.Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.Cancer Res 1995; 55:1933-1936

共引文献106

同被引文献28

  • 1金明娟,陈坤,张扬,张薇,刘冰,张勇晶.XRCC1单核苷酸多态性与结直肠癌风险的关系[J].癌症,2007,26(3):274-279. 被引量:15
  • 2任卓,樊军卫,周崇治,裘国强,贺林,彭志海.X射线损伤修复交叉互补基因1的单核苷酸多态性与散发性结直肠癌易感性相关[J].中华实验外科杂志,2007,24(9):1087-1089. 被引量:9
  • 3Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005 [ J ]. Cancer Epidemiol Biomarkers Prey,2005,14( 1 ) :243-250.
  • 4Doll R, Peto R. The causes of cancer: quantitative estimates of a- voidable risks of cancer in the United States today [ J ]. J Natl Cancer Inst, 1981,66 ( 6 ) : 1191 -1308.
  • 5Thompson LH,West MG. XRCC! keeps DNA from getting stranded [J]. Mutat Res,2000,459( 1 ) :1-18.
  • 6Abdel-Rahman SZ, Soliman AS, Bondy ML,et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt [ J ]. Cancer Lett,2000,159 ( 1 ) :79-86.
  • 7Knipa R,Blasiak J. An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer[J]. J Exp Clin Cancer Res ,2004,23 ( 2 ) :285-294.
  • 8Yeh CC, Sung FC, Tang R, et al. Polymorphisms of the XRCC1, XRCC3,& XPD genes, and colorectal cancer risk: a case-control study in Taiwan [J]. BMC Cancer,2005,5 : 12.
  • 9Hong YC, Lee KH, Kim WC, et al. Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer[ J ]. Int J Cancer, 2005,116(3) :428-432.
  • 10Skjelbred CF, Saebo M, Wallin H, et al. Polymorphisms of the XRCC1 ,XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma,in a Norwegian cohort: a case control study [ J]. BMC Cancer,2006,6:67.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部